Intrasense

Intrasense EBITDA Margin

The EBITDA Margin of Intrasense (ALINS.PA) as of Nov 9, 2026 is -294.42 %. In the previous year, EBITDA Margin was -205.57 % — a change of 43.22% (lower).

EBITDA Margin

-294.42 %

YoY

43.22%

Last updated:

EBITDA Margin of Intrasense is 2025 -294.42 % . EBITDA Margin of Intrasense was 2024 -205.57 % . It decreases by 43.22% lower compared to the previous year.

The Intrasense EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
-18.12 EUR
Jan 1, 2019
-9.76 EUR
Jan 1, 2020
-5.41 EUR
Jan 1, 2021
-14.91 EUR
Jan 1, 2022
-72.11 EUR
Jan 1, 2023
-80.61 EUR
Jan 1, 2024
-205.57 EUR
Jan 1, 2025
-294.42 EUR
The Intrasense EBITDA Margin history
YEAREBITDA MarginYoY
-294.42 %+43.22%
-205.57 %+155.03%
-80.61 %+11.78%
-72.11 %+383.74%
-14.91 %+175.78%
-5.41 %-44.64%
-9.76 %-46.11%
-18.12 %-66.62%
-54.29 %+27.76%
-42.50 %+21.91%
-34.86 %-67.68%
-107.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intrasense Stock analysis

What does Intrasense do? The company Intrasense SA, headquartered in France, is a leading provider of medical image processing software and solutions. The company was founded in 2004 by a group of engineers and has already established itself as a major player in the industry. Intrasense SA offers a wide range of products and solutions for medical image processing. Their software platform Myrian® allows radiologists and doctors to integrate, visualize, and analyze images and data from multiple sources. The platform also provides advanced tools and algorithms for 3D image processing, allowing doctors to analyze and interpret complex medical images. Intrasense SA's products are tailored to the needs of hospitals, clinics, and research institutions to support better medical diagnosis and therapy. Intrasense SA has several divisions that focus on specific medical areas. One of these divisions is oncology. Intrasense SA offers specialized solutions for the diagnosis and treatment of cancer. Their software can perform advanced cancer measurements and enables radiologists to identify and classify lesions related to different types of cancer. Another division of the company is cardiology. Intrasense SA offers advanced solutions for the diagnosis and treatment of heart diseases. Their software allows for precise and comprehensive analysis of heart function and provides valuable information for the assessment of heart conditions. Intrasense SA also has a division for neuroradiology. This division offers advanced solutions for the diagnosis and treatment of neurological disorders. Intrasense SA's platform allows for precise analysis of brain structure and function and provides important information for the evaluation of brain injuries and diseases. Intrasense SA has experienced significant international expansion in recent years. The company now operates branches in France, the United States, Germany, and Italy, and its products are sold worldwide. The rapid growth of the company can be attributed to the quality of its products and high customer satisfaction. Intrasense SA is committed to continuing to develop and provide innovative solutions for medical image processing areas. Their commitment to quality and customer satisfaction has led the company to enjoy a high reputation in the industry. Overall, Intrasense SA is a dynamic and innovative company that specializes in creating solutions that revolutionize medical image processing. They offer products that meet the clinical needs across various medical specialties, including oncology, cardiology, and neuroradiology. Their ability to develop customer-oriented solutions has made the company a key player in the industry in a short period, and it is expected to continue to play a significant role in the advancement of medical image processing in the future. Intrasense is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intrasense stock

EBITDA Margin of Intrasense is -294.42 % in 2025.

EBITDA Margin of Intrasense changed from -205.57 % to -294.42 %, representing a 43.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Intrasense since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Intrasense with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Intrasense

All Key Metrics — Intrasense